---

COMMUNITY MEDICINE EXAM ANSWERS

From Park's Textbook of Preventive and Social Medicine

---

GROUP A - LONG ANSWER QUESTIONS (15 Marks)

---

Q1. Natural History of Disease, Levels of Prevention & Web of Causation in a 45-year-old smoker with Hypertension and MI

Natural History of Disease

Phase 1 - Prepathogenesis Phase

• Host factors: 45-year-old male, smoker, possibly sedentary lifestyle, genetic predisposition
• Agent factors: hyperlipidemia, nicotine, carbon monoxide
• Environmental factors: dietary habits (high fat), stress, air pollution

Phase 2 - Pathogenesis Phase

• Early pathogenesis: Endothelial damage from smoking and hyperlipidemia triggers atherosclerosis; lipid accumulation in vessel walls; foam cells form; fatty streaks develop. The patient is asymptomatic. Blood pressure begins to rise (hypertension develops subclinically).
• Late pathogenesis / Clinical horizon: As atherosclerotic plaques progress and eventually rupture, a coronary thrombus forms. The patient crosses the "clinical horizon" and presents with myocardial infarction - the observable, symptomatic phase.

PREPATHOGENESIS PHASE          |  PATHOGENESIS PHASE
                                |
[Agent-Host-Environment]       | [Early Path.] ---> [Clinical Horizon] ---> [Advanced Disease]
Interaction of risk factors    | Subclinical       Symptoms appear          Recovery/
Smoking, HTN risk factors      | Atherosclerosis,  (MI, Chest pain)         Disability/Death
                                | Endothelial injury
                                |
     <-------- PRIMARY PREVENTION ------><--- SECONDARY ---><--- TERTIARY --->

---

Web of Causation (MacMahon & Pugh)

Genetic        Sedentary      High fat diet
predisposition  lifestyle        |
      |             |            |
      v             v            v
   Obesity -----> Hyperlipidemia
      |                 |
      v                 v
  Hypertension ----> Atherosclerosis -----> Coronary Thrombosis -----> MI
      ^                 ^
      |                 |
   Smoking ---------- Endothelial Damage
   (nicotine,          |
   CO, oxidants)       v
                   Platelet aggregation
      ^
      |
   Diabetes mellitus / Stress / Type A personality

---

Levels of Prevention (Applied to this Patient)

1. Primordial Prevention

• Preventing the emergence of risk factors in childhood
• Discouraging smoking initiation, promoting healthy diet and active lifestyle from childhood
• Mass media campaigns, school health programs
• Interventions: Individual and mass education

2. Primary Prevention (Pre-pathogenesis phase)

• Health promotion: Balanced diet, physical activity, stress management
• Specific protection: Smoking cessation counseling, treatment of hypertension before organ damage, lipid-lowering therapy (statins), low-dose aspirin for high-risk individuals
• WHO approaches: Population (mass) strategy (reduce average BP/cholesterol in population) + High-risk strategy (screen and treat hypertensive individuals)
• Interventions: Health education, legislation (tobacco control), environmental modification

3. Secondary Prevention (Early pathogenesis/Subclinical phase)

• Early diagnosis: Screening for hypertension in adults (BP measurement), ECG stress testing, lipid profile screening, blood glucose testing
• Prompt treatment: Antihypertensives (ACE inhibitors, beta-blockers), statins, antiplatelet therapy
• Lead time: Screening advances diagnosis to before the clinical horizon - the time between detection by screening and when the patient would normally present
• Interventions: Mass screening campaigns, opportunistic case-finding, periodic health check-ups

4. Tertiary Prevention (Post-clinical phase - After MI has occurred)

• Disability limitation: Thrombolysis/PCI for acute MI, cardiac monitoring in ICU, anti-failure medications
• Rehabilitation: Cardiac rehabilitation program (graded exercise, physiotherapy), psychological counseling, vocational rehabilitation (return to work)
• Prevention of recurrence: Long-term antiplatelet (aspirin, clopidogrel), beta-blockers, ACE inhibitors, statins, lifestyle modification

---

Q2. Secondary and Tertiary Prevention - Importance, Modes, and Childhood Pneumonia

Importance of Secondary Prevention

1. Detects subclinical disease - exploits the iceberg phenomenon - vast amounts of undetected disease exist below the clinical horizon
2. Reduces duration of illness - prompt treatment shortens disease course
3. Reduces complications and sequelae
4. Prevents progression from early to advanced disease
5. Reduces transmission of communicable diseases by identifying carriers and sub-clinical cases
6. Cost-effective - treating early disease is cheaper than managing advanced disease
7. Reduces case fatality rates

Importance of Tertiary Prevention

1. Limits disability after disease has already caused damage
2. Maximizes residual function - rehabilitation restores functional capacity
3. Prevents further progression and new complications
4. Improves quality of life
5. Reduces social and economic burden of disability
6. Reintegrates patients into family, social, and vocational life
7. Provides palliative care when cure is impossible

Modes of Intervention

---

Prevention of Childhood Pneumonia

Primary Prevention of Childhood Pneumonia

1. Immunization (most important specific protection):
   • Pneumococcal conjugate vaccine (PCV 10/13) - under Universal Immunization Programme
   • Hib (Haemophilus influenzae type b) vaccine - in pentavalent vaccine
   • Influenza vaccine
   • Measles vaccine (measles predisposes to pneumonia)
   • Pertussis vaccine (DPT)
2. Nutritional interventions: Exclusive breastfeeding for 6 months (passive immunity + nutrition), Vitamin A supplementation, zinc supplementation
3. Environmental measures: Reduction of indoor air pollution (smokeless chulhas, LPG), reducing household crowding, improved ventilation
4. Health promotion: Handwashing with soap, hygiene education for mothers
5. Primordial: Addressing poverty, improving housing and sanitation

Secondary Prevention of Childhood Pneumonia

1. Early case detection: IMNCI (Integrated Management of Neonatal and Childhood Illness) algorithm - classify pneumonia by respiratory rate and chest indrawing:
   • Fast breathing (≥50 bpm in 2-12 months, ≥40 bpm in 1-5 years) = Pneumonia
   • Chest indrawing = Severe pneumonia
   • Danger signs (inability to drink, convulsions, etc.) = Very severe disease/pneumonia
2. Prompt treatment:
   • Non-severe: Oral amoxicillin at home
   • Severe: Hospitalization, parenteral antibiotics (ampicillin + gentamicin or co-amoxiclav)
   • Supportive: oxygen therapy, IV fluids, antipyretics
3. ASHA role: Community-level identification and referral of pneumonia cases
4. CHC/PHC management: Rapid diagnostic assessment, early antibiotic initiation

---

Q3. Iceberg Phenomenon, Lead Time, Uses of Screening, and Disease Selection Criteria

Iceberg Phenomenon of Disease

• The floating tip (above waterline) = clinical cases seen by physicians - the apparent part
• The submerged portion (below waterline) = hidden mass of disease: latent, inapparent, presymptomatic, undiagnosed cases, and carriers
• The waterline = demarcation between apparent and inapparent disease

• Prevalence of disease is always greater than what appears from clinical data alone
• Justifies the need for active case-finding and screening programs
• Epidemiologists study the entire iceberg - not just the clinical tip

---

Lead Time

• Lead time = time gained by screening
• It represents the time during which early treatment can be initiated before symptoms develop
• This is the window of opportunity for secondary prevention to be effective
• Lead time bias: In screening studies, survival appears longer simply because diagnosis was advanced in time (even without any actual prolongation of life) - an important methodological consideration

---

Uses of Screening

1. Early detection of disease at a preclinical/subclinical stage when treatment is more effective
2. Identifies high-risk individuals who need closer surveillance or prophylaxis
3. Estimation of disease burden - helps understand the true prevalence (iceberg)
4. Evaluates effectiveness of prevention and control programs
5. Research - studying the natural history of disease
6. Cost-effective intervention - early treatment is cheaper than treatment of advanced disease
7. Reduces morbidity and mortality by enabling timely intervention
8. Identifies carriers and contacts in communicable diseases
9. Provides epidemiological data for planning health services

---

Criteria (Basis) for Selecting a Disease for Screening (Wilson & Jungner Criteria)

1. The disease:
   • Should be an important health problem (high prevalence/severity)
   • Should have a recognizable early stage (latent/preclinical phase)
   • Should have a known natural history - well understood
   • The natural course of the condition should be adequately understood
2. The test:
   • A suitable screening test must be available
   • The test should be simple, safe, precise, and validated
   • Should be acceptable to the population
   • Should have good sensitivity (few false negatives) and specificity (few false positives)
   • Cost of case-finding should be economically balanced
3. The treatment:
   • Effective treatment must be available and acceptable
   • There should be an agreed policy on whom to treat
   • Adequate facilities for diagnosis and treatment must exist
   • Early treatment should offer advantage over late treatment
4. The screening program:
   • Should be a continuing process (not a one-time effort)
   • Cost-benefit ratio should be favorable
   • Benefits should outweigh risks (physical, psychological, ethical)

---

Q4. Impairment, Disability, Handicap, QoL Impact, Rehabilitation - Below-Knee Amputation

Definitions (WHO/ICIDH Classification)

1. Impairment

• It is at the level of organ or body part
• In this patient: Loss of the lower leg - the anatomical impairment
• Also includes: potential nerve damage, phantom limb pain, wound healing issues
• Impairment is the medical/pathological consequence

2. Disability

• It is at the level of the person/individual
• Functional limitations resulting from the impairment
• In this patient:
  • Inability to walk without prosthesis/aid
  • Difficulty with climbing stairs, running, driving
  • Difficulty with self-care (bathing, dressing)
  • Inability to perform occupational tasks (if standing/walking-dependent work)
  • Difficulty with recreation and sports

3. Handicap

• It is at the level of society/social role
• It is the social consequence of disability
• In this patient:
  • Inability to fulfill his normal social role (breadwinner, father, community member)
  • Economic disadvantage if unable to continue current profession
  • Stigma and discrimination in employment
  • Social isolation and exclusion
  • Dependence on others - loss of independence

---

Comprehensive Impact on Quality of Life and Psychosocial Well-being

• Chronic pain (stump pain, phantom limb pain)
• Altered gait and risk of falls
• Skin problems at stump-prosthesis interface
• Fatigue from increased energy expenditure during ambulation
• Secondary musculoskeletal issues (back pain, hip problems)

• Grief reaction - mourning the lost limb (stages: denial, anger, bargaining, depression, acceptance)
• Body image disturbance - altered self-perception
• Depression and anxiety (very common post-amputation)
• Post-traumatic stress disorder (from the accident itself)
• Loss of self-esteem and confidence
• Fear of being a burden to the family

• Strained interpersonal relationships
• Social withdrawal and isolation
• Altered sexual function and intimacy
• Caregiver burden on family
• Social stigma and discrimination

• Loss of income / job loss
• Cost of prosthesis and ongoing rehabilitation
• Financial dependence on family/government

---

Rehabilitation

Modalities of Rehabilitation Applied to Below-Knee Amputation:

• Acute wound management and stump care
• Pain management (phantom limb pain: gabapentin, amitriptyline, mirror therapy)
• Stump shaping and conditioning (elastic bandaging)
• Prosthetic fitting - prescription and fitting of a trans-tibial (below-knee) prosthesis (patellar tendon-bearing socket)
• Physiotherapy: strengthening residual limb muscles, gait training with prosthesis, balance training
• Occupational therapy: relearning ADLs (activities of daily living)

• Individual counseling and psychotherapy
• Treatment of depression/anxiety (pharmacological and non-pharmacological)
• Peer support groups (amputee support groups)
• Cognitive Behavioral Therapy (CBT) for body image and PTSD
• Family counseling

• Social casework for accessing government benefits and disability allowances
• Removal of architectural barriers at home (grab bars, ramps, modified toilet)
• Disability certification (under Rights of Persons with Disabilities Act, 2016 in India)
• Integration back into social activities and community life

• Vocational assessment - what jobs can this person do?
• Vocational retraining if current job is not feasible
• Job placement assistance
• Sheltered employment if needed
• Under Vocational Rehabilitation Centres (VRCs) managed by MSJE (Ministry of Social Justice and Empowerment)

• Special education provisions
• Inclusive education with appropriate accommodations

---

Q5 & Q6. Dual Burden of Disease - Dengue and Hypertension/Diabetes (Communicable + NCD)

Definition of Communicable Disease (CD)

Epidemiological Triad of Communicable Diseases

1. Agent (infectious agent - bacteria, virus, parasite, fungus):
   • For dengue: Dengue virus (arbovirus, Flaviviridae) - 4 serotypes (DENV 1-4)
   • Properties: infectivity, pathogenicity, virulence, antigenicity
2. Host (susceptible human):
   • Demographic factors: age, sex, race
   • Biological factors: immunity, nutritional status, prior infection
   • Behavioral factors: outdoor activity, clothing, use of repellents
3. Environment:
   • Physical: warm, humid tropical climate favoring Aedes mosquito breeding
   • Biological: vector (Aedes aegypti mosquito)
   • Social: urban density, poor sanitation, water storage practices, open containers

---

Natural History and Risk Factors of Non-Communicable Diseases

Hypertension

• Non-modifiable: Age, male sex, family history, race
• Modifiable: Obesity, high salt intake, physical inactivity, smoking, alcohol, stress, diabetes

Diabetes Mellitus (Type 2)

• Non-modifiable: Age >40, family history, gestational diabetes
• Modifiable: Obesity (especially central), sedentary lifestyle, unhealthy diet (high glycaemic index), smoking, hypertension

---

Methods of Disease Surveillance and Outbreak Investigation

Disease Surveillance

1. Passive surveillance: Health facilities routinely report cases (e.g., IDSP in India). Simple, cheap, but incomplete.
2. Active surveillance: Health workers actively seek out cases (e.g., AFP surveillance for polio). More complete, more expensive.
3. Sentinel surveillance: Selected sentinel sites/providers report cases - detects trends (e.g., influenza sentinel surveillance)
4. Syndromic surveillance: Based on symptom clusters rather than confirmed diagnoses - useful for early outbreak detection
5. Serological surveillance: Based on antibody levels in population samples (e.g., serosurveys for COVID-19)

• "S" form (syndromic): filled by community health workers weekly
• "P" form (presumptive): filled by clinicians weekly
• "L" form (laboratory-confirmed): filled by labs weekly
• Used for dengue, malaria, cholera, influenza surveillance

Outbreak Investigation (Steps)

1. Confirm the existence of an outbreak - verify diagnosis
2. Define and count cases - establish case definition
3. Orient data in terms of time, place, and person (epidemic curve, spot map)
4. Generate hypotheses about source and vehicle
5. Test hypotheses - analytic epidemiology (case-control study)
6. Implement control measures (simultaneously with investigation)
7. Communicate findings - report to health authorities
8. Maintain surveillance to confirm outbreak is over

---

Levels of Prevention - Dengue, Hypertension, Diabetes

---

Q7. Levels of Prevention, Modes of Intervention for COPD and Interest Gaps in NHD of NCDs

Levels of Prevention and Modes of Intervention for COPD

• Policy-level tobacco control (COTPA - Cigarette and Tobacco Products Act, India)
• WHO FCTC (Framework Convention on Tobacco Control)
• Clean Air Acts, reducing biomass fuel use (Ujjwala Yojana)
• Occupational health legislation (dust control in coal mines, textile mills)

• Health promotion: Tobacco cessation (5As - Ask, Advise, Assess, Assist, Arrange), anti-smoking campaigns
• Specific protection: Occupational dust control (PPE, wet drilling, exhaust ventilation), reducing biomass smoke exposure, treating recurrent respiratory infections in childhood
• Environmental measures: Air quality standards, reducing vehicular pollution

• Early detection: Spirometry (FEV1/FVC <0.7 = airflow obstruction) - screening high-risk individuals (smokers >40 years)
• Prompt treatment: Bronchodilators (SABA, LABA, LAMA), inhaled corticosteroids, pulmonary rehabilitation
• GOLD (Global Initiative for COPD) staging: GOLD 1-4 based on FEV1
• Influenza and pneumococcal vaccination to prevent exacerbations

• Disability limitation: Oxygen therapy (LTOT if PaO2 <55 mmHg), pulmonary rehabilitation (graded exercise, breathing exercises)
• Rehabilitation: Vocational rehabilitation, respiratory support devices, psychological support for anxiety/depression
• Lung volume reduction surgery or lung transplant in select cases
• Palliative care in end-stage COPD

---

Interest Gaps (Gaps) in Natural History of NCDs

1. Subclinical phase is prolonged and silent: Unlike communicable diseases, NCDs have very long latent periods (years to decades) before clinical manifestation. The exact timeline is unknown for individuals.
2. No clear "clinical horizon": In communicable diseases, the clinical horizon is relatively predictable. In NCDs (e.g., atherosclerosis, diabetes), progression is gradual and the transition from sub-clinical to clinical is imperceptible.
3. Multiple interacting risk factors: Web of causation makes it difficult to predict individual progression. The relative weight of each risk factor varies.
4. Reversibility is partial and slow: Unlike communicable diseases where treatment cures the infection, NCDs involve permanent structural changes. The natural history after intervention (secondary prevention) is incompletely understood.
5. Genetic-environmental interaction: Gene-environment interactions that determine who among those with risk factors actually develops disease are not fully characterized.
6. Regression of subclinical disease: Whether early atherosclerotic plaques can regress with intervention - not fully established.
7. Long interval between exposure and outcome: Studying NHD of NCDs requires decades-long cohort studies (e.g., Framingham Heart Study), which are expensive and rare in LMIC settings.

---

Q8. Disease Control, Elimination, Eradication; Smallpox Eradication; TB Elimination

Concepts

---

Factors That Led to Successful Eradication of Smallpox

1. Biological factors (agent):
   • Humans were the only reservoir - no animal reservoir
   • No carrier state - disease was always clinically apparent
   • Stable, antigenically uniform virus (only 1 serotype) - vaccine effective against all strains
   • Short incubation period + obvious rash = easy case identification
2. Effective vaccine:
   • Vaccinia vaccine was stable, heat-stable (freeze-dried), effective (>95% protection), cheap, and could be given by anyone
   • Single dose conferred lifelong immunity
   • Bifurcated needle and jet injector made mass vaccination feasible
3. Surveillance and containment strategy:
   • 1967-1977: Global eradication programme by WHO
   • Strategy shifted from mass vaccination to ring vaccination (surveillance-containment): identify case → vaccinate all contacts and neighbors
   • Weekly reporting system (telegram) from all countries
   • Reward system for case reporting
4. International cooperation: WHO led coordinated global effort with all member states participating
5. Political will: Strong commitment at highest levels of government and international bodies
6. Economic resources: Adequate funding - estimated $300 million over 10 years - cheaper than continuing vaccination programs
7. Global certification: Independent commission verified eradication in 1980

---

Why TB is Considered for Elimination Rather Than Eradication

1. Massive reservoir of latent TB: ~1/4 of the world's population has latent TB infection (LTBI) - no clinical disease but viable M. tuberculosis persists. There is no vaccine or drug that completely clears LTBI.
2. Animal reservoirs: M. bovis infects cattle, badgers, and other animals - provides a non-human reservoir.
3. Limitations of available vaccine: BCG vaccine has variable efficacy (0-80%) - does not prevent pulmonary TB reliably, does not prevent transmission, and does not help eliminate LTBI.
4. Drug resistance: MDR-TB, XDR-TB - treatment is prolonged (18-24 months), expensive, and often fails.
5. No rapid diagnostic tools universally available: Microscopy has low sensitivity; culture takes weeks; Xpert MTB/RIF is not universally available in LMICs.
6. Biological characteristics: M. tuberculosis can persist in dormant state for decades; reactivation risk continues throughout life.
7. Social determinants: TB is deeply linked to poverty, malnutrition, overcrowding, HIV - which cannot be eradicated quickly.
8. No proof-of-eradicability: Unlike smallpox, TB has never been eliminated from any large population despite intensive efforts.

---

Q9. Natural History of Disease with Diagram, Levels of Prevention for TB, Disease Surveillance

Levels of Prevention and Modes of Intervention - Tuberculosis

Disease Surveillance - Types

1. Passive surveillance: Routine reporting of TB cases by facilities (NIKSHAY portal in India)
2. Active surveillance: Contact tracing - household contacts of index TB cases screened
3. Sentinel surveillance: Selected facilities with enhanced reporting
4. Drug resistance surveillance: DST (Drug Susceptibility Testing) in sentinel laboratories
5. Cohort surveillance: Treatment outcome monitoring (cure rate, default rate, failure rate, death rate)
6. Laboratory-based surveillance: Xpert positivity rates, culture results

---

GROUP B - SHORT ANSWER QUESTIONS (10 Marks)

---

SAQ 1 & 2. Levels of Prevention and Modes of Intervention

Levels of Prevention (Summary)

Modes of Intervention at Each Level

1. Health promotion: Health education, environmental modification, nutritional interventions, lifestyle changes
2. Specific protection: Immunization, chemoprophylaxis, protection against occupational hazards, use of specific nutrients, protection against carcinogens, avoidance of allergens

1. Early diagnosis: Screening (mass/selective), case-finding, clinical examination, laboratory investigations
2. Prompt adequate treatment: Specific therapy, surgery, chemotherapy

1. Disability limitation: Adequate treatment to arrest disease and prevent complications
2. Rehabilitation: Medical, social, vocational, psychological rehabilitation

---

SAQ 3 & 5. Natural History of Disease (Communicable Disease - Typhoid example)

1. Direct transmission: direct contact, droplet infection, contact with soil/vegetation
2. Indirect transmission:
   • Vehicle-borne: water, food, milk (typhoid, cholera)
   • Vector-borne: mechanical (flies) or biological (malaria - anopheles mosquito)
   • Airborne: droplet nuclei, dust (TB, measles)
   • Fomite-borne: contaminated objects
   • Transplacental (congenital syphilis, rubella, HIV)

---

SAQ 4 & 2 (RPHGMCH). Levels of Prevention in Hypertension

Definition

Changing Pattern of Disease (SAQ 4 - BSMCH)

• Epidemiological transition: India is experiencing a shift from predominantly communicable diseases to a dual burden with rapidly rising NCDs (cardiovascular disease, diabetes, COPD, cancer)
• First transition: Communicable to non-communicable diseases
• Second transition: Acute to chronic disease burden
• Risk factors: urbanization, sedentary lifestyle, unhealthy diets, tobacco use, increasing longevity
• Hypertension, diabetes, and coronary heart disease now among leading causes of mortality in India

Prevention of Hypertension at Each Level

• National salt reduction policy (Food Safety and Standards Authority of India)
• Urban planning: parks, cycling tracks, walkways
• School health programs: promoting healthy diet and physical activity from childhood
• Policies reducing tobacco advertisement and alcohol availability
• Socioeconomic development

• Health promotion: WASH your SALT campaign; DASH diet (Dietary Approaches to Stop Hypertension): fruits, vegetables, low-fat dairy, reduced saturated fat; weight management (BMI <25); aerobic exercise (150 min/week); alcohol ≤2 drinks/day for men; smoking cessation; stress management (yoga, meditation)
• Specific protection: not applicable directly (no vaccine), but treating diabetes and preventing obesity directly reduces hypertension risk

• Screening: National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Disease and Stroke (NPCDCS) - opportunistic screening for adults ≥30 years at all PHC/CHC; BP measurement at every health contact
• Early treatment: Lifestyle modification first (3-6 months); Pharmacotherapy: ACE inhibitors (ramipril), ARBs (losartan), CCBs (amlodipine), thiazide diuretics (hydrochlorothiazide), beta-blockers; Target: <130/80 mmHg (AHA 2017); Stepped care approach
• Self-monitoring: Home BP monitoring; medication adherence support; e-health apps

• Management of target organ damage: Cardiac (echocardiogram, diuretics, ACE-I for LVH); Renal (ACE-I/ARB for proteinuria); Cerebrovascular (stroke rehabilitation, secondary prevention with antiplatelets + statins); Retinal (ophthalmological review)
• Rehabilitation: Cardiac rehabilitation, stroke rehabilitation (physiotherapy, speech therapy, occupational therapy)
• Palliative care in heart failure, ESRD

---

SAQ 6 (RGMCH). Cervical Cancer - Risk Factors, Primary Prevention, and Screening

Major Risk Factors for Cervical Cancer in India

1. HPV (Human Papillomavirus) infection - the most important causative factor (>99% of cervical cancers)
   • High-risk HPV types: 16 and 18 (account for 70% of cases)
   • Others: 31, 33, 45, 52, 58
2. Multiple sexual partners (self or partner)
3. Early age at first intercourse (<18 years)
4. Early marriage and early childbearing
5. High parity (multiparity)
6. Poor genital hygiene (lack of circumcision in male partner)
7. Sexually transmitted infections: Herpes simplex virus type 2, Chlamydia trachomatis
8. Immunosuppression: HIV infection (relative risk 5-10x)
9. Tobacco smoking: Carcinogenic metabolites in cervical mucus
10. Long-term oral contraceptive use (>5 years) - minor risk
11. Low socioeconomic status (poor access to screening and healthcare)
12. Nutritional deficiencies: Vitamin A, C, E deficiency

---

Primary Preventive Measures for Cervical Cancer

1. HPV Vaccination (most important specific protection):
   • Cervarix (bivalent - HPV 16, 18) and Gardasil (quadrivalent - HPV 6, 11, 16, 18) or Gardasil 9 (9-valent)
   • Recommended for girls 9-14 years (pre-sexual debut) - 2 doses (0 and 6 months)
   • 15-26 years: 3 doses
   • India launched national HPV vaccination program (January 2023): Free HPV vaccination for girls aged 9-14 under Universal Immunization Programme (Cervavac - indigenous quadrivalent vaccine by Serum Institute)
   • Can prevent 70-90% of cervical cancers
2. Health education and behavior change:
   • Delayed sexual debut
   • Reduction in number of sexual partners
   • Safe sex practices (condom use) - reduces but does not eliminate HPV risk
   • Tobacco cessation
3. Improved hygiene: Genital hygiene education, promoting male circumcision (reduces HPV carriage in males)
4. Treatment of coexisting STIs: Treatment of herpes, chlamydia
5. Empowerment of women: Education, reduction of child marriage, family planning

---

Screening Methods under the National Programme (NPCDCS/National Cancer Screening Programme)

1. VIA (Visual Inspection with Acetic Acid) - Primary recommended method for low-resource settings in India:
   • 3-5% acetic acid applied to cervix; acetowhite areas indicate CIN/cancer
   • Sensitivity: 70-80%, Specificity: 85-90%
   • Done by trained ANMs and health workers at PHC level
   • Results available immediately (no lab required)
   • Screen-and-treat approach: VIA positive → colposcopy or cryotherapy at same visit
2. VILI (Visual Inspection with Lugol's Iodine):
   • Lugol's iodine applied; normal epithelium stains brown/black; abnormal areas remain saffron/yellow
   • Used as adjunct to VIA
3. Pap Smear (Papanicolaou smear):
   • Cytological examination of cervical cells
   • Requires trained cytopathologist - limited availability at peripheral levels
   • Sensitivity 55-80% (single test); high false-negative rate
   • Recommended at District Hospital/higher levels
4. HPV DNA testing:
   • Highly sensitive (>90%) for high-risk HPV types 16 and 18
   • Recommended as primary screening in updated WHO guidelines (2021)
   • Increasingly being adopted - more expensive but more sensitive
   • Can be done via self-collected vaginal swabs
5. Colposcopy - diagnostic (not screening): For women VIA-positive or Pap-abnormal; direct visualization with magnification and biopsy guidance

---

---

GROUP C - SHORT NOTES (5 Marks)

---

C1. Disability Rates

Types of Disability Rates

• Grade 0: No anaesthesia, no visible deformity or damage
• Grade 1: Anaesthesia present, but no visible deformity or damage
• Grade 2: Visible deformity or damage present (e.g., claw hand, foot drop, lagophthalmos)

• This is a key programme indicator in NLEP - ideally should be <1% of new cases

Significance of Disability Rates

• Assess the magnitude of disability burden in the community
• Evaluate effectiveness of prevention and rehabilitation programs
• Guide resource allocation for rehabilitation services
• Monitor trends (e.g., reduction in Grade 2 leprosy disability with early MDT treatment)
• Used in welfare planning and disability certification policies

India Context

• Census 2011: 2.68 crore persons with disability = 2.21% of population
• Categories: visual, hearing, speech, locomotor, mental illness, mental retardation, multiple disabilities
• Rights of Persons with Disabilities Act 2016: 21 categories of disability recognized; persons with ≥40% disability entitled to benefits

---

C2. DALY (Disability-Adjusted Life Year)

Formula

Components Explained

• Standard life expectancy based on Japanese life tables (longest life expectancy globally)
• A death at age 30 (when life expectancy is 80) = 50 YLLs

• Disability weights range from 0 (perfect health) to 1 (equivalent to death)
• Example: Blindness disability weight ≈ 0.6; deafness ≈ 0.2

Key Features of DALY

1. Social weighting (age weighting): Years lived as a young adult are valued higher than as a child or elderly - reflects society's interest in productivity
2. Time discounting: Future years of health are discounted at 3% per year (accounts for preference for present health over future health)
3. Developed by Murray & Lopez for the World Bank's Global Burden of Disease Study (1993)

Uses of DALY

1. Compare disease burden across different conditions (communicable vs. NCD vs. injuries)
2. Guide health policy - identify priority diseases for resource allocation
3. Cost-effectiveness analysis - "cost per DALY averted" is a standard metric
4. International comparisons between countries
5. Monitor progress in reducing disease burden over time
6. Highlights neglected conditions - e.g., psychiatric/neurological conditions account for 28% of YLD but only 1.4% of all deaths - revealing their huge, often-underestimated burden

Key Findings from GBD Studies

• 5 of the top 10 leading causes of disability worldwide are psychiatric conditions (depression, anxiety, schizophrenia, bipolar disorder, substance use)
• Global DALYs have remained largely stable from 1990-2019 but correcting for population growth shows improvement
• Disease burden has been shifting from communicable diseases to NCDs and injuries, and from premature death to years lived with disability

Limitations

• Disability weights are value-laden and culturally variable
• Data quality varies across countries
• Age weighting and discounting remain controversial
• Does not capture quality of life beyond disability

---

GROUP D - ESSAYS/WRITE-UPS (4 Marks)

---

D1. Monitoring and Surveillance - Differences with Examples

• Monitoring: An ANM weighing all under-5 children monthly and plotting on growth charts - this is growth monitoring
• Surveillance: IDSP collects S/P/L forms weekly from all districts; epidemiologists analyze trends; if cholera cases increase by >25% over 3-week baseline, an outbreak alert is issued and investigation is initiated - this is disease surveillance

---

D2. Health is Multi-Dimensional - Justify

• Absence of disease, injury, or disability
• Normal functioning of organ systems
• Adequate nutrition, fitness, immunity
• Example: A person free from tuberculosis, with adequate haemoglobin and normal BP

• "A state of well-being in which the individual realizes his/her own abilities, can cope with normal stresses, can work productively, and contributes to the community" (WHO definition of mental health)
• Includes emotional stability, cognitive function, absence of anxiety/depression
• Example: Adequate mental health cannot be substituted by physical health alone

• Ability to fulfill social roles and relationships
• Social support networks, community integration
• Freedom from social exclusion and discrimination
• Example: A person with controlled diabetes who maintains family and occupational roles

• Sense of purpose, meaning, and inner peace
• Harmony with one's values and belief system

• Ability to engage in productive, meaningful work

• These dimensions are interdependent - poor mental health worsens physical illness (depression worsens recovery from MI) and vice versa
• A purely biomedical model (absence of disease) is inadequate
• Health promotion must address all dimensions - not just curative care
• DALY captures both physical and mental health burden in a single metric

---

D3. Infant Mortality Rate is a Sensitive Indicator of Community Health

• Neonatal Mortality Rate (deaths <28 days): Reflects antenatal care, safe delivery practices, care of newborn
• Post-neonatal Mortality Rate (28 days - 1 year): Reflects infection control, nutrition, immunization, safe water

---

D4. Disability and Handicap are not Synonymous

• Impairment: Loss of lower limb (anatomical)
• Disability: Inability to walk without prosthesis, difficulty climbing stairs
• Handicap: Two scenarios -

---

D5. Primary Prevention is the Best Strategy for Non-Communicable Diseases

• Well-established (causal, not just associated)
• Highly prevalent in the population
• Modifiable through individual and population-level interventions

• Antihypertensives control but do not reverse target organ damage
• Chemotherapy has significant toxicity and limited efficacy for many cancers
• Dialysis and transplants for diabetic nephropathy are expensive and scarce in LMICs

---

D6. Identifying the Weakest Point in the Chain of Transmission - Rabies and COVID-19

---

• Why: Stray dogs are the source of >95% of human rabies cases in India
• Intervention at reservoir: Animal Birth Control (ABC) programme + mass dog vaccination (rabies vaccine to >70% of dog population achieves herd immunity and breaks transmission)
• Why this is strongest intervention: Eliminates the source completely rather than just protecting individual humans
• Example: Bhutan achieved near-zero human rabies by systematically vaccinating dogs - before widespread human vaccination

• Portal of exit/transmission: Responsible pet ownership, leash laws
• Portal of entry/host: Post-exposure prophylaxis (PEP) - vaccine + RIG after bite (secondary prevention, not primary); Pre-exposure prophylaxis for veterinarians (primary protection of susceptible host)

---

• Why: SARS-CoV-2 has no animal reservoir that drives ongoing human transmission (unlike rabies); the virus spreads primarily person-to-person via respiratory droplets
• Interventions at mode of transmission:
  • Physical distancing (≥1 meter) - reduces droplet contact
  • Masking (especially N95) - reduces aerosol transmission
  • Ventilation - reduces aerosol concentration indoors
  • Isolation of cases - removes infectious source
  • Contact tracing and quarantine - breaks transmission chains

• Susceptible host: Vaccination (primary prevention - most powerful intervention at host level)
• Portal of entry: Hand hygiene, PPE for healthcare workers

---

D7. Life Expectancy is One of the Best Indicators of a Country's Level of Development

• Human Development Index (HDI) - uses life expectancy as one of three components (alongside education and income) - UNDP
• Physical Quality of Life Index (PQLI) - uses life expectancy + IMR + literacy
• These are standard tools for international development comparisons

---

D8 & D10. Growth Monitoring and Nutritional Surveillance are not the Same

---

D9. Primordial Prevention is More Appropriately Used in Non-Communicable Diseases

• Banning tobacco sale to minors (prevents tobacco initiation - prevents the risk factor)
• School physical activity programs and healthy canteens (prevents childhood obesity)
• Urban planning with parks and cycling infrastructure (prevents sedentary lifestyle)
• FSSAI regulations reducing trans-fat and salt in packaged foods
• Prohibition of surrogate advertising for alcohol

---

D11. Prevalence Rate of <1 in Leprosy Will Not Ensure Elimination - Comment

• Active case detection, contact screening, and post-exposure prophylaxis (single-dose rifampicin for contacts)
• Addressing social determinants (overcrowding, malnutrition)
• Sustained disability prevention and community-based rehabilitation
• Development of leprosy vaccine and rapid diagnostic tools

---

D12. Lung Cancer Can Be Controlled by Primary Preventive Measures

• ~85-90% of lung cancer cases are attributable to tobacco smoking (cigarettes, bidis, smokeless tobacco)
• Smokers have 20-30x higher risk of lung cancer vs. non-smokers
• The dose-response relationship is clear - more pack-years = greater risk
• If tobacco were eliminated, lung cancer incidence would fall by >80-85%

• Passive smoking (secondhand smoke): Accounts for ~25% of lung cancer in non-smokers - preventable through smoke-free laws
• Occupational carcinogens: Asbestos (mesothelioma + lung cancer), radon gas, chromium, arsenic, nickel - all preventable through occupational health measures (PPE, engineering controls, substitution)
• Indoor air pollution: Biomass fuel smoke (chulha) in rural India - Ujjwala Yojana (LPG distribution) directly reduces this risk
• Outdoor air pollution: Vehicular and industrial emissions - air quality regulations

• Tobacco control legislation: COTPA (India), pictorial health warnings, high tobacco taxes, ban on advertisements, ban on smoking in public places → proven to reduce smoking prevalence
• WHO MPOWER framework: Monitor, Protect (from smoke), Offer cessation support, Warn, Enforce bans, Raise taxes
• Smoking cessation services: Tobacco cessation clinics in India (iQuit, Tobacco Cessation Centres at medical colleges) - quitting reduces lung cancer risk progressively; after 10 years of cessation, risk is halved
• Radon mitigation: Testing homes in high-radon areas, building codes for ventilation
• Asbestos regulation: India banned chrysotile asbestos in construction (partial ban); complete ban needed

---

D13. Sentinel Surveillance is Useful for Early Outbreak Detection

• IDSP sentinel surveillance: State-level sentinel hospitals report all cases of specific syndromes weekly
• Influenza sentinel surveillance (ICMR/WHO): ~50+ sentinel sites across India (medical colleges + district hospitals) performing virological surveillance for influenza and SARI (Severe Acute Respiratory Illness)
• HIV sentinel surveillance: Annual surveys at ANC and STI clinic sentinel sites to estimate HIV prevalence trends
• Rotavirus sentinel surveillance: Hospital-based sentinel sites for rotavirus gastroenteritis in children <5 years
• Dengue sentinel surveillance: NVBDCP-designated sites

---

D14. Disability Limitation and Rehabilitation are Important Components of NLEP

• Anaesthesia (loss of sensation in hands, feet, face) → injury goes unnoticed → progressive tissue destruction
• Muscle paralysis: Claw hand (ulnar nerve), foot drop (common peroneal nerve), lagophthalmos (facial nerve)
• Grade 2 deformities: Visible, permanent deformities that cause severe stigma and social exclusion
• Lepra reactions (Type 1 and Type 2): Acute nerve damage during/after MDT - require urgent medical intervention (steroids) to prevent permanent disability

• POD (Prevention of Disability): Regular examination of hands, feet, and eyes at MDT clinics; early detection and treatment of lepra reactions with steroids; self-care training (patients taught to care for anaesthetic feet/hands - daily inspection, soaking, applying oil, use of footwear)
• Lagophthalmos management: Eye care (lubricating drops, protective glasses, surgical correction - tarsorrhaphy)
• Physiotherapy: Passive and active exercises to prevent contractures; tendon transfer surgeries for claw hand, foot drop
• MCR (Micro Cellular Rubber) footwear: Custom-designed footwear to protect anaesthetic feet from plantar ulcers - provided free under NLEP

• Medical rehabilitation: Surgical reconstruction - corrective surgeries for claw hand, foot drop, lagophthalmos (performed at District Leprosy Officers and referred centres)
• Social rehabilitation: Integration of leprosy-cured persons into mainstream society; combating stigma through NLEP IEC activities; repeal of anti-leprosy laws (India repealed discriminatory laws in states)
• Economic/Vocational rehabilitation: Under the Sparsh Leprosy Awareness Campaign and collaboration with NGOs (e.g., The Leprosy Mission); skill development and self-help groups for persons affected by leprosy; provision of aids and appliances (crutches, wheelchairs)
• Community-Based Rehabilitation (CBR): Integrating persons with leprosy-related disabilities into mainstream CBR programmes

• Grade 2 Disability Rate among new cases (should be <1% ideally)
• New cases with Grade 2 disability - WHO monitors this as key indicator
• Reduction in these indicators is a programmatic goal

---